fda approves semaglutide for cardiovascular risk reduction to Reduce Kidney Disease, Death in Adults With Type 2 Diabetes, Chronic Kidney Disease Recent study finds that semaglutide

Epigenomics of leukemia: from mechanisms to therapeutic applications

Pregnant or breastfeeding women should not use Ozempic either

Researchers comparing how to mix peptides with bac water or how much bacteriostatic water to add to peptides should follow proper reconstitution protocols to minimize contamination and ensure accurate dosing

This can lead to lower blood pressure over time

We intend to support, not replace, the doctor-patient relationship.

To our knowledge, this was the first trial to assess the body weight-lowering effect of an oral glucagon-like peptide-1 (GLP-1) analogue (semaglutide 50 mg taken once per day) in adults with overweight or obesity, without type 2 diabetes, OASIS 1 investigators reported in the Lancet this week